Ray Dalio acquired 14.4 Thousand Neogenomics shares worth $116 Thousand. That's 0.00% of their equity portfolio (661st largest holding). The first Neogenomics trade was made in Q1 2023. Since then Ray Dalio bought shares two more times and sold shares on five occasions. The investor's estimated purchase price is $206 Thousand, resulting in a loss of 44%.